Catheter-based pH monitoring: Use in evaluation of gastroesophageal reflux disease symptoms (on and off therapy)

Gastrointestinal Endoscopy Clinics of North America

Volumn 15, Issue 2, 2005, Pages 289-306

  DeVault, Kenneth R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; CATHETER; CLINICAL TRIAL; DISEASE SEVERITY; DRUG MEGADOSE; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; HYPOPHARYNX; LARYNGOPHARYNGEAL REFLUX; LOWER ESOPHAGUS SPHINCTER; MANOMETRY; PH MEASUREMENT; PRIORITY JOURNAL; REVIEW; STOMACH ACID; STOMACH PH; SYMPTOMATOLOGY;

EID: 13944254056     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.giec.2004.10.003     Document Type: Review

References (99)

1. J. Spencer Prolonged pH recording in the study of gastro-oesophageal reflux Br J Surg 56 1969 912 914
2. W.H. Falor, J.R. Hansell, and B. Chang Outpatient 24-hour esophageal monitoring by pH telemetry Gastroenterology 78 1980 1163 1168
3. A.G. Klauser, N.E. Schindbeck, and S.A. Muller-Lissner Symptoms in gastro-oesophageal reflux disease Lancet 135 1990 205 208
4. L. Terea, M. Fein, and M.P. Ritter Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease? Am Surg 63 1997 933 936
5. T.L. Venables, R.D. Newland, and A.C. Patel Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice Scand J Gastroenterol 32 1997 965 973
6. M.E. Numans, J. Lau, and N.J. de Witt Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease. A meta-analysis of diagnostic test characteristics Ann Intern Med 140 2004 518 527
7. D.A. Katzka, V. Paoletti, and L. Leite Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive antireflux therapy Am J Gastroenterol 92 1997 907 909
8. L.R. Lundell, J. Dent, and J.R. Bennett Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification Gut 45 1999 172 180
9. K.H. Fuchs, T.R. DeMeester, and M. Albertucci Specificity and sensitivity of objective diagnosis of gastroesophageal reflux disease Surgery 102 1987 575 580
10. M.G. Patti, U. Diener, and A. Tamburini Role of esophageal function tests in diagnosis of gastroesophageal reflux disease Dig Dis Sci 46 2001 597 602
11. J.T. Salminen, J.A. Tuominen, and O.J. Ramo Oesophageal acid exposure: higher in Barrett's oesophagus than in reflux oesophagitis Ann Intern Med 31 1999 46 50
12. S. Tuttle, F. Fuffin, and A. Bettarella The physiology of heartburn Ann Intern Med 55 1961 292 300
13. G. Vitale, W. Cheadle, and M. Michel Computerized 24-hour ambulatory esophageal pH monitoring and esophagogastroduodenoscopy in the reflux patients. A comparative study Ann Surg 200 1984 724 729
14. L.F. Johnson, and T.R. DeMeester Twenty-four-hour pH monitoring of the distal esophagus Am J Gastroenterol 62 1974 323 332
15. C. Farup, L. Kleinman, and S. Sloan The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life Arch Intern Med 161 2001 45 52
16. T. Gislason, C. Janson, and P. Vermeire respiratory symptoms and nocturnal gastroesophageal reflux: a population-based study of young adults in three European countries Chest 121 2002 158 163
17. W.C. Orr, M.L. Allen, and M. Robinson The pattern of nocturnal and diurnal esophageal acid exposure in the pathogenesis of erosive mucosal damage Am J Gastroenterol 89 1994 509 512
18. T.R. DeMeester, L.F. Johnson, and G.J. Joseph Patterns of gastroesophageal reflux in health and disease Ann Surg 184 1976 459 469
19. V.A. Saraswat, R.K. Dhiman, and A. Mishra Correlation of 24-hr esophageal pH patterns with clinical features and endoscopy in gastroesophageal reflux disease Dig Dis Sci 39 1994 199 205
20. J. Lagergren, R. Bergstrom, and A. Lindgren Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 1999 825 831
21. T. Tomonaga, Z.T. Awad, and C.J. Filipi Symptom predictability of reflux-induced respiratory disease Dig Dis Sci 47 2002 9 14
22. R.D. Davis, C.L. Lau, and S. Eubanks Improved lung allograft function after fundoplication in patients with gastroesophageal reflux undergoing lung transplantation J Thorac Cardiovasc Surg 125 2003 533 542
23. G.J. Weiner, J.E. Richter, and J.B. Copper The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring Am J Gastroenterol 83 1988 358 361
24. S. Singh, J.E. Richter, and L.A. Bradley The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain Dig Dis Sci 38 1993 1402 1408
25. R. Breumelhof, and A.J.P.M. Smout The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording Am J Gastroenterol 86 1991 160 164
26. B.L.A.M. Weusten, L.M.A. Akkermans, and G.P. van Berge Henegouwen Ambulatory combined oesophageal pressure and pH monitoring: relationships between pathological reflux, oesophageal dysmotility and symptoms of esophageal dysfunction Eur J Gastroenterol Hepatol 5 1993 1055 1060
27. J.D. Gardner, S. Rodriguez-Stanley, and M. Robinson Integrated acidity and the pathophysiology of gastroesophageal reflux disease Am J Gastroenterol 96 2001 1363 1370
28. A.G. Klauser, H.C. Schindlbeck, and S.A. Muller-Lissner Is long-term esophageal pH monitoring of clinical value? Am J Gastroenterol 84 1989 362 366
29. G. Shi, S. Bruley des Varannes, and C. Scarpignato Reflux related symptoms in patients with normal oesophageal exposure to acid Gut 37 1995 457 464
30. K.S. Trimble, S. Douglas, and A. Pryde Clinical characteristics and natural history of symptomatic, but no excess gastroesophageal reflux Dig Dis Sci 40 1995 1098 1104
31. R.G.P. Watson, T.C.K. Tham, and B.T. Johnston Double-blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux-the "sensitive esophagus Gut 40 1997 587 590
32. J.P. Galmiche, and C. Scarpignato Esophageal pH monitoring. Functional evaluation in esophageal disease Front Gastrointest Res 22 1994 71 108
33. H.G.T. Lam, R. Breumelhof, and J.M.M. Roelofs What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig Dis Sci 39 1994 402 409
34. H.G. Hewson, J.W. Sinclair, and C.B. Dalton Twenty four-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain Am J Med 90 1991 576 583
35. R.S. Irwin, C.L. French, and F.J. Curley Chronic cough due to gastroesophageal reflux disease: Clinical, diagnostic and pathogenetic aspects Chest 104 1993 1511 1517
36. K. Olden, and G. Triadafilopoulos Failure of initial 24-hour pH monitoring to predict refractoriness and intractability in reflux esophagitis Am J Gastroenterol 86 1991 1142 1146
37. M. Kusano, K. Ino, and T. Yamada Interobserver and intraobserver variation in endoscopic assessment of GERD using the "Los Angeles" classification Gastrointest Endosc 49 1999 700 704
38. M.F. Vaezi, and J.E. Richter Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease Gastroenterology 111 1996 1192 1199
39. R.C. Orlando Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective Am J Gastroenterol 91 1996 1692 1696
40. P.L. Peghini, P.O. Katz, and N.A. Bracy Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors Am J Gastroenterol 93 1998 763 767
41. R. Tutuian, P.O. Katz, and D.O. Castell A PPI is a PPI is a PPI: lesions from prolonged intragastric pH monitoring Gastroenterology 18 2000 A17
42. P.O. Katz Lessons learned from intragastric pH monitoring J Clin Gastroenterol 33 2001 107 113
43. T.M. Ours, W.K. Fackler, J.E. Richter, and M.F. Vaezi Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure Am J Gastroenterol 98 2003 545 550
44. Y.M. Fouad, P.O. Katz, and D.O. Castell Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors Aliment Pharamacol Ther 13 1999 1467 1471
45. B. Kuo, and D.O. Castell Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls Am J Gastroenterol 91 1996 1532 1538
46. S. Oberg, T.R. DeMeester, and J.H. Peters The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure J Thorac Cardiovasc Surg 117 3 1999 572 580
47. T. Loughney, C.L. Maydonovitich, and R.K. Wong Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus Am J Gastroenterol 93 1998 916 919
48. R. Ouatu-Lascar, and G. Triadafilopoulos Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus Am J Gastroenterol 93 1998 711 716
49. R.W. Yeh, L.B. Gerson, and G. Triadafilopoulos Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal and intragastric pH in patients with Barrett's esophagus Dis Esophagus 16 2003 193 198
50. R. Fass, R.E. Sampliner, and I.B. Malagon Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor Aliment Pharmacol Therap 14 2000 597 602
51. R. Srinivasan, P.O. Katz, and A. Ramakrishnan Maximal acid reflux control for Barrett's oesophagus: feasible and effective Aliment Pharmacol Therap 15 2001 519 524
52. J.G. Hatlebakk, P.O. Katz, and B. Kuo Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily Aliment Pharmacol Ther 12 1998 1235 1240
53. C.J. Loughlin, and J.A. Koufman Paroxysmal laryngospasm secondary to gastroesophageal reflux Laryngoscope 106 1996 1502 1505
54. T.R. Eubanks, P.E. Omelanczuk, and N. Maronian Pharyngeal pH monitoring in 222 patients with suspected laryngeal reflux J Gastrointest Surg 5 2001 183 190
55. H.E. Mattox, J.E. Richter, and J.W. Sinclair Gastroesophageal pH step-up inaccurately locates proximal border of lower esophageal sphincter Dig Dis Sci 37 1992 1185 1191
56. W.G. Patterson, and B.W. Murat Combined ambulatory esophageal manometry and dual-probe pH-metry in evaluation of patients with chronic unexplained cough Dig Dis Sci 39 1994 1117 1125
57. P.F. Schnatz, J.A. Castell, and D.O. Castell Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to direct therapy Am J Gastroenterol 91 1996 1715 1718
58. M.F. Vaezi, P.L. Schroeder, and J.E. Richter Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring, how are they? Am J Gastroenterol 92 1997 825 829
59. R. Dobhan, and D.O. Castell Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring Am J Gastroenterol 88 1993 25 29
60. J.M. Wo, J.G. Hunter, and J.P. Waring Dual-channel ambulatory esophageal pH monitoring: a useful diagnostic tool? Dig Dis Sci 42 1997 2222 2226
61. M.F. Vaezi, P.L. Schroeder, and J.E. Richter Reproducibility of proximal probe pH parameters in 24-hour esophageal pH monitoring Am J Gastroenterol 92 1997 825 829
62. P. Jacob, P. Kahrilas, and G. Herzon Proximal esophageal pH-metry in patients with "reflux Laryngitis Gastroenterology 100 1991 305 310
63. S.M. Harding, J.E. Richter, and M.E. Cuzzo Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome Am J Med 100 1996 395 405
64. J.B.Y. So, S.M. Zeitels, and D.W. Rattner Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication Surgery 124 1998 28 32
65. S.E. Attwood, T.R. DeMeester, and J.A. Wernly Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus Surgery 106 1989 764 770
66. D. Garcia-Compean, M.V. Gonzalez, and G. Galindo Prevalence of gastroesophageal reflux disease in patients with extraesophageal symptoms referred from otolaryngology, allergy and cardiology practices: a prospective study Dig Dis 18 2000 178 182
67. S.J. Sontag, T.G. Schell, and T.Q. Miller Prevalence of oesophagitis in asthmatics Gut 33 1992 849 856
68. S.M. Harding, M.R. Guzzo, and J.E. Richter 24-h esophageal pH testing in asthmatics. Respiratory symptom correlation with esophageal acid events Chest 115 1997 654 659
69. M.P.R. McNally, C.L. Maydonovitch, and A. Prosek Evaluation of gastroesophageal as a cause of idiopathic hoarseness Dig Dis Sci 34 1989 1900 1904
70. G.J. Weiner, J.A. Kaufman, and W.C. Wu Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-hour ambulatory pH monitoring Am J Gastroenterol 84 1989 1503 1508
71. C. Timon, T. O'Dwyer, and D. Cagney A globus pharyngeus: long-term follow-up and prognostic factors Ann Otol Rhinol Laryngol 100 1991 351 354
72. G. Kjellen, and L. Brudin Gastroesophageal reflux disease and laryngeal symptoms. Is there a causal relationship? ORL J Otorhinolarygol Relat Spec 56 1994 287 290
73. J.A. Wilson, A. White, and N.P. von Haacke Gastroesophageal reflux and posterior laryngitis Ann Oto Rhinol Laryngol 98 1989 405 410
74. J.A. Koufman Laryngopharyngeal reflux testing Ear Nose Throat J 82 Suppl 2 2002 S14 S18
75. R.S. Irwin, J.K. Zawacki, and F.J. Curley Chronic cough as the sole presenting manifestation of gastroesophageal reflux Am Rev Respir Dis 140 1989 1294 1300
76. J.P. Waring, L. Lacayo, and J.E. Hunger Chronic cough and hoarseness in patients with severe gastroesophageal disease: diagnosis and response to therapy Dig Dis Sci 40 1995 1093 1097
77. J.M. Wo, and D.O. Castell Exclusion of meal periods from ambulatory 24-hour pH monitoring may improve diagnosis of esophageal acid reflux Dig Dis Sci 39 1994 1601 1607
78. J. Richter, M. Vaezi, and C.R. Stasney Baseline pH measurements for patients with suspected signs and symptoms of reflux laryngitis Gastroenterology 126 2004 A536 A537
79. M. Vaezi, J. Richter, and C.R. Stasney A randomized, double blind, placebo-controlled study of acid suppression for the treatment of suspected laryngopharyngeal reflux Gastroenterology 126 2004 A22
80. J.M. Wo, W.J. Frist, and G. Gussack Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study Am J Gastroenterol 92 1997 2160 2165
81. K.R. DeVault, and D.O. Castell Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease Am J Gastroenterol 94 1999 1434 1442
82. J.P. Waring, J.G. Hunger, and M. Oddsdottir The preoperative evaluation of patients considered for laparoscopic antireflux surgery Am J Gastroenterol 90 1995 35 38
83. G.M.R. Campos, J.H. Peters, and T.R. DeMeester Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication J Gastrointest Surg 3 1999 292 300
84. P.J. Kahrilas, and E.M.M. Quigley Clinical esophageal pH recording: a technical review for practice guidelines development Gastroenterology 110 1996 1982 1996
85. R.V. Lord, A. Kaminski, and S. Oberg Absence of gastroesophageal reflux disease in a majority of patients taking acid suppression medications after Nissen fundoplication J Gastrointest Surg 6 2002 3 10
86. C.J. Martin, M.R. Cox, and R.J. Cade Collis-Nissen gastroplasty fundoplication for complicated gastro-oesophageal reflux disease Aust N Z J Surg 62 1992 126 129
87. G. Triadafilopoulous, J.K. DiBaise, and T.T. Nostrant The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the US open label trial Gastrointest Endosc 55 2002 149 156
88. C.J. Filipi, G.A. Lehman, and R.I. Rothstein Transoral, flexible endoscopic suturing for treatment of GERD: a multicenter trial Gastrointest Endsoc 53 2001 416 422
89. D. Pleskow, R. Rothstein, and S. Lo Endoscopic full-thickness plication for the treatment of GERD: a multicenter trial Gastrointest Endosc 59 2004 163 171
90. D.A. Johnson, R. Ganz, and J. Aisenberg Endoscopic, deep mural implantation of Enteryx for the treatment of GERD: 6-month follow-up of a multicenter trial Am J Gastroenterol 98 2003 250 258
91. S. Mattioli, V. Pilotti, and M. Spangaro Reliability of 24-hour home esophageal monitoring in diagnosis of gastroesophageal disease Dig Dis Sci 34 1989 71 78
92. A.A.M. Masclee, A.C.A.M. De Best, and R. De Graaf Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease Scand J Gastroentol 25 1990 225 230
93. D.W. Murphy, Y. Yuan, and D.O. Castell Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans Dig Dis Sci 34 1989 649 656
94. M.I. Booth, J. Stratford, and T.C.B. Dehn Patient self-assessment of test-day symptoms in 24-h pH-metry for suspected gastroesophageal reflux disease Scand J Gastroenterol 36 2001 795 799
95. K.R. DeVault, D.D. Ferguson, and E.M. Ward Extended (48hr) monitoring significantly increases the yield of ambulatory pH testing Gastroenterology 126 2004 A18
96. T.J. Lee, J.E. Pandolfino, and K. Goelz Esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction (SCJ) Gastroenterology 124 2003 A72
97. V.F. Eckardt, B. Dilling, and G. Bernhard The impact of open access 24-h pH-metry on the diagnosis and management of esophageal reflux disease Am J Gastroenterol 94 1999 616 621
98. R. Fass, R. Hell, and R.E. Sampliner Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities Dig Dis Sci 44 1999 2263 2269
99. P.L. Lim, M.J. Gibbons, and E.J. Crawford The effect of lifestyle changes on results of 24-h ambulatory oesophageal pH monitoring Eur J Gastroenterol Hepatol 12 2000 655 656